In immune and cancer cells, intracellular butyrate increases the number of acetylated histones by preventing the activity of the enzyme histone deacetylase (HDAC), which controls the levels of transcription factors and proteins that are engaged in important regulating pathways [19]. This evidence concerns the gene HDAC9 and cancer.